Tag Archives: Rx&D

Canada’s Competitiveness in the Pharmaceutical Sector

Canada’s Research-Based Pharmaceutical Companies (Rx&D) recently released their Patented Medicine Prices Review Board’s (PMPRB) 2011 Annual Report. Rx&D members continue to meet their 1987 research and development (SR&ED) goals of 10 percent of sales, but the international and domestic environments … Continue reading

Posted in SR&ED News | Tagged , , , | Leave a comment